Literature DB >> 20100410

Predictors of sentinel lymph node metastasis in melanoma.

Ali Cadili1, Kelly Dabbs.   

Abstract

BACKGROUND: Several studies have examined the correlation between patient and tumour characteristics and sentinel lymph node (SLN) metastasis in patients with melanoma. Although most studies have identified Breslow thickness as an important factor, results for other variables have been conflicting. Much of this variability is probably because of differences in measurement techniques and reporting practices at different institutions. We sought to identify the predictors of SLN melanoma metastasis in our institution and patient population.
METHODS: We performed a retrospective chart review of 348 patients with malignant melanoma who underwent SLN biopsy at a single institution from January 1999 to April 2007. We compared multiple variables related to patient demographics, primary tumour characteristics and SLN characteristics between patients in the positive and negative SLN groups.
RESULTS: Breslow thickness and nodular tumour type were independent factors significantly correlated with a positive SLN biopsy result in our study. Head and neck tumour location correlated with a lower likelihood of positive SLN status in univariate but not multivariate analyses.
CONCLUSION: This study confirms the status of Breslow thickness as a reproducible predictor of positive SLN status. We also found that nodular type was predictive of positive SLN status, an outcome that has not been reported by others.

Entities:  

Mesh:

Year:  2010        PMID: 20100410      PMCID: PMC2810014     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  14 in total

1.  Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Authors:  Vernon K Sondak; Jeremy M G Taylor; Michael S Sabel; Yue Wang; Lori Lowe; Amelia C Grover; Alfred E Chang; Alan M Yahanda; James Moon; Timothy M Johnson
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

2.  Melanoma thickness and histology predict sentinel lymph node status.

Authors:  C L Nguyen; E F McClay; D J Cole; P H O'Brien; W E Gillanders; J S Metcalf; J C Maize; P L Baron
Journal:  Am J Surg       Date:  2001-01       Impact factor: 2.565

3.  The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

Authors:  Sandra C Paek; Kent A Griffith; Timothy M Johnson; Vernon K Sondak; Sandra L Wong; Alfred E Chang; Vincent M Cimmino; Lori Lowe; Carol R Bradford; Riley S Rees; Michael S Sabel
Journal:  Cancer       Date:  2007-01-01       Impact factor: 6.860

4.  Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.

Authors:  Laura L Kruper; Francis R Spitz; Brian J Czerniecki; Douglas L Fraker; Anne Blackwood-Chirchir; Michael E Ming; David E Elder; Rosalie Elenitsas; Dupont Guerry; Phyllis A Gimotty
Journal:  Cancer       Date:  2006-11-15       Impact factor: 6.860

5.  Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

Authors:  Susan B Kesmodel; Giorgos C Karakousis; Jeffrey D Botbyl; Robert J Canter; Robert T Lewis; Peter M Wahl; Kyla P Terhune; Abass Alavi; David E Elder; Michael E Ming; DuPont Guerry; Phyllis A Gimotty; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Journal:  Ann Surg Oncol       Date:  2005-04-19       Impact factor: 5.344

6.  Melanoma and tumor thickness: challenges of early diagnosis.

Authors:  M A Richard; J J Grob; M F Avril; M Delaunay; X Thirion; P Wolkenstein; P Souteyrand; B Dreno; J J Bonerandi; S Dalac; L Machet; J C Guillaume; J Chevrant-Breton; C Vilmer; F Aubin; B Guillot; M Beylot-Barry; C Lok; N Raison-Peyron; P Chemaly
Journal:  Arch Dermatol       Date:  1999-03

7.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

Authors:  J E Gershenwald; W Thompson; P F Mansfield; J E Lee; M I Colome; C H Tseng; J J Lee; C M Balch; D S Reintgen; M I Ross
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

8.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

9.  Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.

Authors:  S Mraz-Gernhard; R W Sagebiel; M Kashani-Sabet; J R Miller; S P Leong
Journal:  Arch Dermatol       Date:  1998-08

10.  Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis.

Authors:  A Bonett; D Roder; A Esterman
Journal:  Med J Aust       Date:  1986-06-23       Impact factor: 7.738

View more
  8 in total

1.  Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas.

Authors:  Dale Han; Gang Han; Monica T Duque; Steven Morrison; Stanley P Leong; Mohammed Kashani-Sabet; John Vetto; Richard White; Schlomo Schneebaum; Barbara Pockaj; Nicola Mozzillo; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  Breslow thickness and nodular tumour type.

Authors:  Viroj Wiwanitkit
Journal:  Can J Surg       Date:  2011-02       Impact factor: 2.089

3.  Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.

Authors:  Richard J B Walker; Nicole J Look Hong; Marc Moncrieff; Alexander C J van Akkooi; Evan Jost; Carolyn Nessim; Winan J van Houdt; Emma H A Stahlie; Chanhee Seo; May Lynn Quan; J Gregory McKinnon; Frances C Wright; Michail N Mavros
Journal:  Ann Surg Oncol       Date:  2022-06-08       Impact factor: 4.339

4.  Prediction of sentinel node status and clinical outcome in a melanoma centre.

Authors:  Vera Teixeira; Ricardo Vieira; Inês Coutinho; Rita Cabral; David Serra; Maria José Julião; Maria Manuel Brites; Anabela Albuquerque; João Pedroso de Lima; Américo Figueiredo
Journal:  J Skin Cancer       Date:  2013-12-25

5.  Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

Authors:  Domenico Bellomo; Suzette M Arias-Mejias; Chandru Ramana; Joel B Heim; Enrica Quattrocchi; Sindhuja Sominidi-Damodaran; Alina G Bridges; Julia S Lehman; Tina J Hieken; James W Jakub; Mark R Pittelkow; David J DiCaudo; Barbara A Pockaj; Jason C Sluzevich; Mark A Cappel; Sanjay P Bagaria; Charles Perniciaro; Félicia J Tjien-Fooh; Martin H van Vliet; Jvalini Dwarkasing; Alexander Meves
Journal:  JCO Precis Oncol       Date:  2020-04-14

6.  Melanoma: clinical, evolutive and histopathological characteristics of a series of 136 cases.

Authors:  Juliana Polizel Ocanha-Xavier; José Cândido Caldeira Xavier-Junior; Mariângela Esther Alencar Marques
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

7.  In Vivo Longitudinal Tracking of Lymphangiogenesis and Angiogenesis in Cutaneous Melanoma Mouse Model Using Multifunctional Optical Coherence Tomography.

Authors:  Pei-Yu Lai; Tai-Yu Shih; Yu-Huan Chang; Ya-Shuan Chou; Ting-Hua Wu; Yu-Ya Su; Chung-Hsing Chang; Wen-Chuan Kuo
Journal:  JID Innov       Date:  2021-03-18

8.  Predictors of occult lymph node metastasis in cutaneous head and neck melanoma.

Authors:  Jonathan S Ni; Tyler A Janz; Shaun A Nguyen; Eric J Lentsch
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2019-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.